Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Technology in Cancer Research & Treatment|July 23, 2008
A new preclinical 3-dimensional agarose colony formation assayYoshinori Kajiwara, Sonali Panchabhai, Victor A LevinBMC Cancer|June 26, 2007
Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomasVictor A Levin, Sandra Ictech, Kenneth R HessCancer Chemotherapy and Pharmacology|November 2, 2011
A systematic approach to the management of patients with brain metastases of known or unknown primary siteAthanassios P Kyritsis, Sofia Markoula, Victor A LevinCancer|November 17, 2011
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic gliomaPierre Giglio, Megha Dhamne, Kenneth R Hess, et al.Nutrition and Cancer|February 9, 2011
Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agentsAthanassios P Kyritsis, Melissa L Bondy, Victor A LevinCNS Oncology|January 31, 2018
Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomasVictor A Levin, Sandra E Ictech, Kenneth R HessNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 22, 2022
Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital "Flipbooks" to Control Systems TheoryBenjamin M Ellingson, Victor A Levin, Timothy F CloughesyProteome Science|January 27, 2012
Protein and phosphoprotein levels in glioma and adenocarcinoma cell lines grown in normoxia and hypoxia in monolayer and three-dimensional culturesVictor A Levin, Sonali Panchabhai, Li Shen, et al.International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Effect of bevacizumab on radiation necrosis of the brainJavier Gonzalez, Ashok J Kumar, Charles A Conrad, et al.Oncotarget|November 20, 2020
Effect of eflornithine on mutation frequency in temozolomide-treated U87MG cellsNoymi Yam, Jason Levin, Zhengzheng Bao, et al.Pageof 6